This is an audio transcript of the Unhedged podcast episode: ‘Is Big Tech spending too much money?’ ...

The Kimberly-Clark/Kenvue transaction is one of the worst-received major merger deals in recent years. Investors wondered why ...

In other news, Apple suppliers Qorvo and Skyworks plan to combine and metal card maker Composecure offers a bid for Husky ...

Kimberly-Clark has agreed to acquire Johnson & Johnson (J&J) consumer health spinout Kenvue for $48.7bn. One of America’s ...

Despite a headline beat and decent revenue forecast, the poor reaction to the update from AI and data analytics darling ...

The recent publicity could allow the company to get a good deal on Kenvue, which makes Tylenol, Band-Aids, and other ...

Kimberly-Clark is buying Tylenol maker Kenvue in a cash and stock deal worth about $48.7 billion, creating a huge consumer ...

Fintel reports that on November 4, 2025, Morgan Stanley maintained coverage of Kimberly-Clark (NasdaqGS:KMB) with a ...

The merger will bring together brands such as Huggies, Kleenex, Aveeno, and Tylenol, with Kimberly-Clark shareholders set to ...

While the canard that many mergers fail to provide a return to shareholders does not appear to be supported by the data, ...

Evercore also said Kimberly’s move expands its footprint into two stable, cash-generative global categories, personal hygiene and consumer health, that have high barriers to entry and rational pricing ...